Klaus Hans
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 18
- Lung Cancer Research Studies 18
- Peptidase Inhibition and Analysis 3
- Epidemiology 11
- Neuroendocrine Tumor Research Advances 10
- Multiple and Secondary Primary Cancers 1
- Co-authors
- M. Wolf (10 shared papers)Peter Drings (10 shared papers)Rolf Holle (8 shared papers)Klaus HAVEMANN (11 shared papers)Manfred Heim (4 shared papers)Monika Heidi Serke (1 shared paper)Thomas Blankenburg (1 shared paper)Hans Schweisfurth (1 shared paper)
- Journals
- Lung Cancer (6 papers)Journal of Clinical Oncology (3 papers)European Journal of Cancer (2 papers)Cancer (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- GermanyNetherlandsChina
In The Last Decade
Klaus Hans
18 papers receiving 564 citations
Peers
Comparison fields: 5 of 51
- Oncology 412
- Pulmonary and Respiratory Medicine 255
- Epidemiology 154
- Otorhinolaryngology 12
- Molecular Biology 94
Countries citing papers authored by Klaus Hans
This map shows the geographic impact of Klaus Hans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Hans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Hans more than expected).
Fields of papers citing papers by Klaus Hans
This network shows the impact of papers produced by Klaus Hans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Hans. The network helps show where Klaus Hans may publish in the future.
Co-authors
The 25 scholars most cited alongside Klaus Hans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 162 | |
| 2 | 1991 | 122 | |
| 3 | 1987 | 72 | |
| 4 | 1987 | 55 | |
| 5 | 1997 | 55 | |
| 6 | 1991 | 42 | |
| 7 | Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer. | 1994 | 38 |
| 8 | [Ambulatory laparoscopic cholecystectomy is as effective as hospitalization and from a social perspective less expensive: a randomized study]. | 2001 | 34 |
| 9 | 1997 | 15 | |
| 10 | 1991 | 9 | |
| 11 | 1991 | 8 | |
| 12 | 1987 | 3 | |
| 13 | 1983 | 2 | |
| 14 | 1994 | 2 | |
| 15 | 2006 | 2 | |
| 16 | 1986 | 1 | |
| 17 | 1993 | 1 | |
| 18 | 1997 | 1 | |
| 19 | 2000 | 1 | |
| 20 | 2009 | 1 |
About Klaus Hans
Klaus Hans is a scholar working on Oncology, Epidemiology, Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine, having authored 21 papers that have together received 626 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (18 papers), Neuroendocrine Tumor Research Advances (10 papers), Cancer therapeutics and mechanisms (8 papers), Lung Cancer Treatments and Mutations (6 papers), Peptidase Inhibition and Analysis (3 papers), Lung Cancer Diagnosis and Treatment (2 papers), Cancer Mechanisms and Therapy (1 paper) and Multiple and Secondary Primary Cancers (1 paper). The work is most often cited by research in Oncology (412 citations), Pulmonary and Respiratory Medicine (255 citations), Epidemiology (154 citations), Otorhinolaryngology (12 citations) and Molecular Biology (94 citations). Klaus Hans has collaborated with scholars based in Germany, Netherlands and China. Frequent co-authors include M. Wolf, Peter Drings, Rolf Holle, Klaus HAVEMANN, Manfred Heim, Monika Heidi Serke, Thomas Blankenburg, Hans Schweisfurth, Wolfgang Schuette and Angelika Reißig. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, European Journal of Cancer, Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.